Priscilla Sugianto M.D., M.B.A. is a Principal at Vivo Capital. Prior to Vivo, Priscilla worked at C-Bridge Capital, as an Assistant Vice President on the Investment team, where she was involved in all biopharma investment processes. In addition to equity investment, she was also involved in licensing, royalty, debt, and cross-border transactions. She also has experience in the digital health space, with the following companies Flare Capital, Doctor on Demand, and Virta Health.
Ms. Sugianto received her B.S. in Biochemistry, summa cum laude, from University of California Los Angeles. Ms. Sugianto earned her M.D. from Stanford University School of Medicine and M.B.A from Stanford Graduate School of Business. While at Stanford and UCLA, she undertook research in drug discovery in hematology, oncology, and dermatopathology under the support of NSF, NIH, and Amgen. Her work has been published in multiple peer-reviewed journals, including: Cell Metabolism, Molecular Pharmacology, and Developmental Cell.